Life sciences company leaders planning for growth and stability in the coming year have plenty of issues and trends on which to focus. Regulatory changes, both domestically and internationally, must always be monitored. Advances in AI technology promise to have an increasingly larger impact on growth and operations. Mergers and acquisitions in the industry continue to require life sciences companies to be vigilant for opportunities.
In this podcast, Grant Thornton National Managing Partner for Life Sciences Zara Muradali discusses what she regards as the most important considerations life sciences leaders need to focus on in the coming year, including:
- How high interest rates are affecting M&A opportunities
- How pre-revenue life sciences companies are being affected by tax regulations and how to move toward solutions
- Where AI will continue to affect life sciences companies in research, in relations with regulators, and in organization ethics
Find out what lies ahead for life sciences companies in 2024 in our latest industry series podcast.
PODCAST
Life Sciences Industry: Top issues of 2024
What are the top issues that leaders need to keep in mind for 2024?
6:58 | Transcript
Zara Muradali
National Industry Managing Principal, Life Sciences, Grant Thornton
Contact:
Zara Muradali
National Industry Managing Partner, Life Sciences
Zara is the National Industry Managing Partner of Grant Thornton’s Life Sciences practice.
Boston, Massachusetts
Industries
- Life sciences
- Healthcare
- Technology, media & telecommunications
- Private equity
Service Experience
- Corporate Tax
Top issues for 2024 in other industries
Our life sciences featured industry insights
No Results Found. Please search again using different keywords and/or filters.